ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: PUB278

Cystic Autosomal Dominant Alport Syndrome Masquerading as Polycystic Kidney Disease: Implications for Family Screening andTransplantation

Session Information

Category: Genetic Diseases of the Kidneys

  • 1201 Genetic Diseases of the Kidneys: Cystic

Authors

  • Wongboonsin, Janewit, Brigham and Women's Hospital, Boston, United States
  • Verwillow, Anna, Brigham and Women's Hospital, Boston, Massachusetts, United States
  • Savige, Judith A., The University of Melbourne, Melbourne, Victoria, Australia
  • Onuchic-Whitford, Ana C., Brigham and Women's Hospital, Boston, Massachusetts, United States
Introduction

Autosomal dominant polycystic kidney disease (ADPKD) and Alport syndrome (AS) are two common monogenic kidney diseases. While their phenotypes are typically distinct, renal cysts may occur in autosomal dominant AS (ADAS), potentially leading to diagnostic confusion. Herein, we describe a family where a prior diagnosis of ADPKD was corrected to ADAS, resulting in implications for family screening and transplantation.

Case Description

A 61-year-old woman presented to our clinic for evaluation as a kidney donor for her brother with ADPKD. She had persistent microscopic hematuria since age 38, negative cystoscopy, normal kidney function and one kidney cyst. Review of her brother’s case revealed that 4 months prior, at age 72 and after years without medical follow-up, he presented to another hospital in renal failure and was started on hemodialysis. He was reportedly diagnosed with ADPKD after an ultrasound demonstrated bilateral kidney cysts and genetic testing found a variant in PKD1. We further evaluated him in our clinic with an MRI that showed small, atrophic kidneys (~8cm) with scattered small (<1.5cm) bilateral cysts. Review of his genetic panel revealed a heterozygous variant of uncertain significance in PKD1 (p.Asn2353Ser) and a heterozygous likely pathogenic variant in COL4A4 (p.Gly481Val – a glycine substitution in Gly-X-Y motif). His sister’s genetic test identified the same 2 variants, and the PKD1 variant was deemed Benign. His diagnosis was thus reverted and both siblings were diagnosed with ADAS. Audiologic screening revealed mild (sister) and moderate (brother) bilateral sensorineural hearing loss. Another sibling tested negative for the COL4A4 variant and became a kidney donor for the brother, who was transplanted successfully.

Discussion

The phenotypic heterogeneity of AS may pose a challenge for its clinical diagnosis. The identification of kidney cysts in AS further complicates this, adding AS as a differential diagnosis for cystic diseases. Thorough family history, review of clinical course, and careful visual inspection of renal imaging become important steps to avoid misdiagnosis. This case also highlights the key role of genetic testing, especially in the setting of atypical imaging, advanced chronic kidney disease, and assessment of family members as kidney donors.